{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:43:47Z","timestamp":1792640627508,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.medcli.2023.09.018","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T12:12:17Z","timestamp":1699877537000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hidradenitis supurativa"],"prefix":"10.1016","volume":"162","author":[{"given":"Marcos A.","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.09.018_bib0305","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0310","series-title":"Quelques cas historiques en dermatologie","first-page":"177","article-title":"Aristide Verneuil et la maladie de Verneuil","author":"Halioua","year":"2010"},{"key":"10.1016\/j.medcli.2023.09.018_bib0315","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: An update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0325","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: A sex and age adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0330","first-page":"3","article-title":"Conociendo la epidemiolog\u00eda de la hidradenitis supurativa","volume":"34","author":"Martorell Calatayud","year":"2021","journal-title":"Monograf\u00edas de Dermatolog\u00eda"},{"key":"10.1016\/j.medcli.2023.09.018_bib0335","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2340\/00015555-2176","article-title":"Hidradenitis suppurativa disproportionately affects African Americans: A single-center retrospective analysis","volume":"95","author":"Vlassova","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0340","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: A systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0345","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa?-15 years after","volume":"29","author":"Zouboulis","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0350","first-page":"1065","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"19","author":"Wang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.medcli.2023.09.018_bib0355","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/jcm9103095","article-title":"Association of Human Leukocyte Antigens Class II variants with susceptibility to hidradenitis suppurativa in a caucasian Spanish population","volume":"9","author":"Ocejo-Vinyals","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2023.09.018_bib0360","doi-asserted-by":"crossref","first-page":"15250","DOI":"10.3390\/ijms232315250","article-title":"The role of hormones in hidradenitis suppurativa: A systematic review","author":"Abu Rached","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2023.09.018_bib0365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjd.17093","article-title":"Hormonal, stem cell and Notch signalling as possible mechanisms of disease in hidradenitis suppurativa: A systems-level transcriptomic analysis","volume":"180","author":"Gauntner","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0370","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bjd.20520","article-title":"Novel evidence of androgen receptor immunoreactivity in skin tunnels of hidradenitis suppurativa: Assessment of sex and individual variability","volume":"185","author":"Yu","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0375","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jdv.14894","article-title":"Insulin resistance in hidradenitis suppurativa: A case-control study","volume":"32","author":"Vilanova","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0380","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00403-019-02018-4","article-title":"Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa","volume":"312","author":"Gonz\u00e1lez-L\u00f3pez","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.medcli.2023.09.018_bib0385","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5114\/ada.2021.107932","article-title":"Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0390","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/exd.14132","article-title":"Association of retinol binding protein4 (RBP4) and ghrelin plasma levels with insulin resistance and disease severity in non-diabetic patients with hidradenitis suppurativa","volume":"29","author":"Gonz\u00e1lez-L\u00f3pez","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0395","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/1346-8138.16484","article-title":"Biomarkers of endothelial dysfunction and atherosclerosis in hidradenitis suppurativa","volume":"49","author":"Gonz\u00e1lez-L\u00f3pez","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0400","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.3390\/ijms231911280","article-title":"Microbiome in hdradenitis suppurativa-What we know and where we are heading","volume":"24","author":"\u015awierczewska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2023.09.018_bib0405","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/exd.13885","article-title":"Bacterial biofilm is associated with higher levels of regulatory T cells in unaffected hidradenitis suppurativa skin","volume":"28","author":"Andersen","year":"2019","journal-title":"Exp. Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0410","doi-asserted-by":"crossref","first-page":"e2022191","DOI":"10.5826\/dpc.1204a191","article-title":"Alterations of the human gut microbiome in patients with hidradenitis suppurativa: A case-control study and review of the literature","volume":"12","author":"\u00d6\u011f\u00fct","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.medcli.2023.09.018_bib0415","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jaci.2022.02.003","article-title":"Insights into hidradenitis suppurativa","volume":"149","author":"van Straalen","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0420","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00011-017-1074-y","article-title":"The critical role of macrophages in the pathogenesis of hidradenitis suppurativa","volume":"66","author":"Shah","year":"2017","journal-title":"Inflamm Res"},{"key":"10.1016\/j.medcli.2023.09.018_bib0425","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.3390\/ijms24098428","article-title":"New insight into the molecular pathomechanism and immunomodulatory treatments of hidradenitis suppurativa","volume":"24","author":"Molinelli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2023.09.018_bib0430","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjmed.2022.09.025","article-title":"A Practical guide for Primary Care providers on pimely diagnosis and comprehensive care strategies for hidradenitis suppurativa","volume":"136","author":"Garg","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.medcli.2023.09.018_bib0435","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semerg.2015.12.005","article-title":"Actualizaci\u00f3n en hidrosadenitis supurativa en Atenci\u00f3n Primaria","volume":"43","author":"Garc\u00eda-Mart\u00ednez","year":"2017","journal-title":"Semergen"},{"key":"10.1016\/j.medcli.2023.09.018_bib0440","first-page":"14","article-title":"Manifestaciones cl\u00ednicas de la hidradenitis supurativa","volume":"34","author":"Martorell Calatayud","year":"2021","journal-title":"Monograf\u00edas de Dermatolog\u00eda"},{"key":"10.1016\/j.medcli.2023.09.018_bib0445","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.medcli.2023.09.018_bib0450","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: Latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.medcli.2023.09.018_bib0455","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes","volume":"73","author":"van der Zee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0460","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/jdv.16183","article-title":"Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: Results of a prospective study","volume":"34","author":"Martorell","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0465","series-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk, R RH (edr.), Dermatologic surgery, principles and practice. second edition","first-page":"623","author":"Hurley","year":"1989"},{"key":"10.1016\/j.medcli.2023.09.018_bib0470","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective Scoring of Hidradenitis Suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0475","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: A parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2023.09.018_bib0480","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamadermatol.2017.5890","article-title":"A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa","volume":"154","author":"Hessam","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0485","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): A novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0490","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.medcli.2023.09.018_bib0495","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0500","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.det.2023.02.001","article-title":"Hidradenitis Suppurativa","volume":"41","author":"Jenkins","year":"2023","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.medcli.2023.09.018_bib0505","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0510","doi-asserted-by":"crossref","first-page":"e151872","DOI":"10.1172\/jci.insight.151872","article-title":"Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa","volume":"6","author":"Hua","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.medcli.2023.09.018_bib0515","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: A systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0520","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12944-020-01377-6","article-title":"Atherogenic index of plasma is associated with the severity of hidradenitis suppurativa: A case-control study","volume":"29","author":"Hern\u00e1ndez","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.medcli.2023.09.018_bib0525","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0530","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial Infarction and cerebrovascular accident in patients with hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0535","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaad.2016.03.025","article-title":"Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS)","volume":"75","author":"Gonz\u00e1lez-L\u00f3pez","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0540","doi-asserted-by":"crossref","first-page":"e0190568","DOI":"10.1371\/journal.pone.0190568","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa","volume":"13","author":"Gonz\u00e1lez-L\u00f3pez","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2023.09.018_bib0545","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.3504","article-title":"Bone metabolism in patients with hidradenitis suppurativa: A case-control study","volume":"102","author":"Navarro","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0550","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/bjd\/ljad028","article-title":"The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: A narrative review","volume":"188","author":"Mendes-Bastos","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0555","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.3390\/jcm11237240","article-title":"Current medical and surgical treatment of hidradenitis suppurativa. A comprehensive review","volume":"11","author":"Ocker","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2023.09.018_bib0560","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40257-021-00667-8","article-title":"Medical management of hidradenitis suppurativa with non-biologic therapy: What's new?","volume":"23","author":"Ghanian","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0565","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000515450","article-title":"Topical 15% resorcinol Is associated with high treatment satisfaction in patients with mild to moderate hidradenitis suppurativa","volume":"238","author":"Docampo-Sim\u00f3n","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.medcli.2023.09.018_bib0570","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2023.09.018_bib0575","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1159\/000524121","article-title":"Intralesional treatments in hidradenitis suppurativa: A systematic review","volume":"238","author":"Cuenca-Barrales","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.medcli.2023.09.018_bib0580","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1038\/s41598-020-70176-x","article-title":"Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa","volume":"10","author":"Salvador-Rodr\u00edguez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.medcli.2023.09.018_bib0585","doi-asserted-by":"crossref","first-page":"e15161","DOI":"10.1111\/dth.15161","article-title":"Dapsone in hidradenitis suppurativa: A case series of 56 patients","volume":"34","author":"L\u00f3pez-Llunell","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.medcli.2023.09.018_bib0590","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/pharmaceutics15051351","article-title":"Efficacy and safety of biologics and small molecules for moderate-to-severe hidradenitis suppurativa: A systematic review and network meta-analysis","volume":"15","author":"Tsai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.medcli.2023.09.018_bib0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.ad.2023.05.015","article-title":"Narrative review and update on biologic and small molecule drugs for hidradenitis suppurativa: An entity with a promising future","author":"Mansilla-Polo","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.medcli.2023.09.018_bib0600","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ad.2019.04.008","article-title":"Systematic review of light-based treatments for hidradenitis suppurativa","volume":"111","author":"Gracia Caza\u00f1a","year":"2020","journal-title":"Actas Dermosifiliogr (Engl Ed)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323006036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323006036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T20:44:00Z","timestamp":1707770640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775323006036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0025775323006036"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.09.018","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis supurativa","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}